A recent Klimas/Broderick study had a lot of interesting things in it: the gender divide, and the illumination of possibly key immune and metabolic factors, but the most intriguing thing about the study was its potential precision.

The study possibly identified specific pathways associated with a powerful cytokine that could be tweaked with drugs to help people with ME/CFS. While much more study is needed, no one has developed this precise of an approach to treatment before. One hopes this is the future for ME/CFS.

Find out more in this Simmaron Research Foundation sponsored blog:

New Pathways: A Step Towards Fine-Tuning Treatments for ME/CFS?


A BIG thanks to the 320 people who helped make Health Rising's fundraising drive a success!

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thanks for subscribing! :)

Pin It on Pinterest

Share This